Alzheimer’s care, quality of life improve with innovative Immersion Room
By
Jessica R. Towhey
Aug 01, 2024
A creative new room at a Long Island, NY, nursing home may serve as a model for improving the quality of life and care through non-pharmacological interventions for residents diagnosed with Alzheimer’s...
BREAKING: FDA approves new experimental drug to treat early Alzheimer’s
By
Alicia Lasek
Jan 06, 2023
The Food and Drug Administration has approved the experimental Alzheimer’s drug Leqembi (lecanemab-irmb) for clinical use in patients with early disease.
Two new studies identify potential warning signs of cognitive decline in older adults
By
John Roszkowski
Oct 13, 2023
Older adults who show subtle decline on standard memory and cognitive tests may be at increased risk for developing mild cognitive impairment, a precursor to dementia, according to the results of a new...
Medicare’s plan to cover Alzheimer’s drugs hinges on patient data registries
By
Alicia Lasek
Jun 02, 2023
Medicare Part B will cover Alzheimer’s drugs with traditional FDA approval, CMS announced Thursday. Prescribing clinicians must participate in a patient data registry.
Taking it to the streets: Reimagining dementia
By
Mary Fridley
Charles de Vilmorin
Oct 30, 2023
When Reimagining Dementia: A Creative Coalition for Justice launched “Taking It to the Streets,” a global campaign that took place during the week of Sept. 18 to 24, 2023, one of the first people to...